ICPR 2024, 6-8 June > Speakers

ICPR 2024 Speakers will be announced early 2024

Katrin Preller

Senior Researcher, Psychologist, and Neuroscientist at Yale University / University of Zurich, Switzerland

David Nichols

Founding President of the Heffter Research Institute / Professor Emeritus of Chemistry at Purdue University, United States

Kim Kuypers

Associate Professor at Faculty of Psychology and Neuroscience at Maastricht University, The Netherlands

Rick Doblin

Founder and Executive Director at MAPS, the Multidisciplinary Association for Psychedelic Studies, United States

Amanda Feilding

Founder and Executive Director of the Beckley Foundation, United Kingdom

David Nutt

Professor of Neuropsychopharmacology and head of the Neuropsychopharmacology Unit in the Division of Brain Sciences, Department of Medicine, Imperial College London

Erika Dyck

Professor and Canada Research Chair in the History of Health & Social Justice at the University of Saskatchewan

Roland Griffiths

Professor in the Departments of Psychiatry and Neurosciences at the Johns Hopkins University, United States

Gitte Moos Knudsen

Professor at Rigshospitalet, University of Copenhagen, Denmark

Paul Stamets

Founder of Fungi Perfecti and CEO of MycoMedica Life Sciences PBC, United States

Friederike Holze

Postdoctoral researcher at University Hospital Basel, Switzerland

Peter Gasser

Psychiatrist and Psychotherapist / President of Swiss Medical Society for Psycholytic Therapy, Switzerland

Janis Phelps

Director of the CIIS Center for Psychedelic Therapies and Research, United States

Mendel Kaelen

Founder and CEO at Wavepaths, United Kingdom

Monnica Williams

Research Chair for Mental Health Disparities, University of Ottawa. Principal Investigator for a multi-site study on MDMA-assisted psychotherapy for PTSD, Canada

Bernardo Kastrup

Executive Director of Essentia Foundation / Author, Philosopher, Computer Scientist, The Netherlands

Sonya Faber

Partner at Bioville Gmbh & MSL at Angelini Pharma. BoD member at Chacruna Institute, United States

Matthias Liechti

Professor of clinical pharmacology and internal medicine at the University Hospital Basel, Switzerland

Anna Becker

Clinical researcher on psychedelic substances at the University Hospital Basel, Switzerland

Torsten Passie

Professor of Psychiatry and Psychotherapy at Hannover Medical School, Germany

Patricia Pisters

Professor of humanities and media studies at the University of Amsterdam

Charles Raison

Director of Clinical and Translational Research for Usona Institute. Director of Research on Spiritual Health for Emory Healthcare, United States

Leonie Schneider

Co-Founder of PsyPAN and facilitator on the ACER Integration programme, United Kingdom

Bill Richards

Psychologist at Johns Hopkins Center for Psychedelic & Consciousness Research and Director of Therapy at Sunstone Therapies, United States

Jennifer Schmidt

Director of Preclinical Research and Development at Transcend Therapeutics, United States

Ian Roullier

Co-Founder of the Psychedelic Participant Advocacy Network (PsyPAN), United Kingdom

Emmanuelle Schindler

Assistant Professor of Neurology at Yale School of Medicine, United States

Michael Mullette

COO at MAPS Public Benefit Corporation, United States

Heval Özgen

Psychiatrist & Associate professor at LUMC

Joost Breeksema

Executive Director at the OPEN Foundation and PhD candidate at the Psychiatry Departments of the UMCG, The Netherlands

Natasha Mason

Researcher of drug-induced Neuroadaptations and their influences, Maastricht University, United States

Erwin Krediet

Researcher & Psychologist at ARQ National Psychotrauma Centre and Vice Chair at the OPEN Foundation, The Netherlands

Isabel Wießner

Neuroscientist investigating the effects of Ayahuasca & DMT on EEG brain activity, Federal University of Rio Grande do Norte, Germany

Pedram Dara

Head of Operations at the OPEN Foundation and Conference Manager at ICPR 2022, The Earth

Johanna Hilla Sopanen

Coordinator of Education & Training at Psychedelics Today, University of Exeter, United Kingdom

Tijmen Bostoen

Psychiatrist and Researcher at ARQ Centum ‘45/ Leiden University Medical Center

Meg Spriggs

Post Doctoral Researcher, Centre for Psychedelic Research, Imperial College London, United Kingdom

Matthew Baggott

Neuroscientist and CEO of Tactogen, United States

Corine de Boer

Chief Medical Officer, MD, PhD, MAPS Public Benefit Corporation, United States

Tehseen Noorani

Senior Lecturer in Clinical & Community Psychology and Anthropology at the University of East London, United Kingdom

Emma Eckernäs

PhD student in Clinical Pharmacology, University of Gothenburg, Sweden

S. Parker Singleton

Computational Biologist at Cornell University, United States

Lisa Luan

PhD student at the Centre for Psychedelic Research, Imperial College London, United Kingdom

Joao Ribeiro

Founder of Liminal Minds and Associate Researcher at the Centre for Philosophy of Science of the University of Lisbon, Portugal

Ashleigh Murphy-Beiner

Clincal Psychologist Trainee, Imperial College London, United Kingdom

Jos ten Berge

Associate Professor in Art History at the VU University Amsterdam, The Netherlands

Maria Amato

Researcher, Health Screener & Practicum Training Coordinator, The Synthesis Institute, The Netherlands

Michael Kramer

Researcher of philosophy and phenomenology of psychedelic experiences, United States

Kirran Ahmad

Clinical Research Fellow / Anaesthetist, Centre for Psychedelic Research Imperial and Blessings of the Forest, United Kingdom

Juuso Kähönen

Philosophy Researcher Exploring Self-Transcendence and Values. Helsinki University, Finland

Carolina Seybert

Clinical Psychologist, Champalimaud Foundation, Portugal

Kelan Thomas

Associate Professor of Clinical Sciences at Touro University California College of Pharmacy, United States

Roberta Murphy

Medical Psychotherapist, South West London at St. George's NHS Trust, Ireland

David Dupuis

Social Anthropologist and Clinical Psychologist (INSERM, Paris)

Michelle Baker Jones

Psychotherapeutic counsellor, Imperial College London, United Kingdom

Mateo Sanchez Petrement

Philosophy Researcher focused on the political potentials of psychedelics, Spain

Ilana Berlowitz

Clinical Researcher on Indigenous Psychoactive Use, University of Ben, Faculty of Medicine, Swritzerland

Vincent Moon

Independent French Filmmaker & Radical Sound Explorer, France

Maggie Kiraga

Director of Research at Qualified Citizen, University of Maastricht, Canada

Elliot Marseille

Founding Director of the Global Initiative for Psychedelic Science Economics at UC Berkeley, United States

Stephanie Muller

Doctoral Fellow for CONICET, University of Buenos Aires, Germany

Christopher Timmermann

President of the Foundation for the Study of Human Consciousness, Imperial College London, Chile

Julia Bornemann

PhD Candidate Researching Treatment of Chronic Pain using Psychedelics, Imperial College London, United States

David Erritzoe

Clinical Senior Lecturer Consultant & Psychiatrist, Imperial College London, United Kingdom

Christine Hauskeller

Professor of Philosophy, Founder of the Philosophy and Psychedelics Research Group, University of Exeter, United Kingdom

Dino Luethi

Pharmacodynamics and Pharmacokinetics Reseracher, Switzerland

Kate Godfrey

Post-Doctoral Researcher Leading the Implementation of EEG to Study Psychedelic Effects on the Brain, New Zealand

James Close

Researcher of Psychedelic drugs used in Pain Management and Fibromyalgia, Imperial College London, United Kingdom

Shayla Love

Senior Staff Writer at Vice Media, United States

Winston De La Haye

Consultant General & Addiction Psychiatrist, University Hospital of the West Indies, Jamaica

Florence Butlen-Ducuing

Clinical Psychiatrist & Scientific Senior Specialist in the Human Medicines Division, European Medicines Agency, The Netherlands

Vincent Verroust

PhD candidate in the history of science at the University of Picardie - Jules Vernes

Judy Ashworth

Vice President, Chief Medical Officer, and Rx Strategic Services at Pinney Associates & CMO at Harm Reduction Theraputics, UCLA, United States

Houman Farzin

Palliative Care Physician and Psychedelic Therapist, McGill University, Montreal, Canada

Brigitte Adriaensen

Professor of Hispanic Studies at Radboud University Nijmegen & Professor of Literacy at the Open University, The Netherlands

Peter Sjöstedt-Hughes

Co-Founder of the Philosophy of Psychedelics Exeter Researcher Group, University of Exeter, Exeter, United Kingdom

Drummond McCulloch

Neurobiology Research Unit, Rigshospitalet, Copenhagen, Denmark

Mark Juhan

PhD Student at the University of Exeter, United Kingdom

Ivar Goksøyr

Specialist in Clinical Psychology, Psykologvirke AS, Norway

Johannes Reckweg

Neuropsychology and Psychopharmacology, PhD Candidate at Maastricht University, The Netherlands

Jordan Sloshower

Psychedelic Instructor, Yale University, Department of Psychiatry, United States

Jeffrey Guss

Clinical Assistant Professor of Psychiatry, NYU School of Medicine, United States

J. Christian Greer

Postdoctoral Fellow, Harvard University's Center for the Study of World Religions, United States

Christian B. M. Poulie

Medicinal Chemist focusing on CNS related Radiochemical Projects, University of Copenhagen, Denmark

Robert Schoevers

Professor of Psychiatry and Head of Department Psychiatry, University Medical Center Groningen, The Netherlands

Amir Vudka

Doctor of Film and Media Culture, University of Amsterdam, The Netherlands

Ruben Laukkonen

Cognitive Neuroscientist, Vrije Universiteit Amsterdam, The Netherlands

Marco Aqil

Founder of APRA and PhD Candidate at the Spinoza Centre for Neuroimaging, The Netherlands

Bill Brennan

Psychologist and member of the Clinical Research team at Cybin Inc., NYU, United States

Balazs Szigeti

Inventor of the "Self-Binding" Methodology, Imperial College London, United Kingdom

Brian Pace

Affiliate Scholar of the Center for Psychedelic Drug Research and Education at The Ohio State University, United States

Patrick Everitt

Independent Researcher of Western Esotericism and Philosophy, Ireland

Sander Bos

Multimedia Artist Reflecting the Psychedelic Experience by Leveraging New Technologies, The Netherlands

Matthew Wall

Psychologist and Neuroscientist Specializing in fMRI's, Imperial College London, United Kingdom

Edward Jacobs

Research Fellow and Science Officer at the Beckley Foundation, University of Oxford, United Kingdom

Aidan Lyon

Analytical Philosopher focusing on Wisdom, Uncertainty, and Decision Making, University of Amsterdam, Australia

André van der Braak

Professor of Comparative Philosophy of Religion, Vrije Universiteit Amsterdam, The Netherlands

Daan F. Oostveen

Philosopher and Scholar of Religion, Utrecht University, The Netherlands

Yogi Hendlin

Assistant Professor and Editor-in-Chief of Journal Biosemiotics, Erasmus University, The Netherlands

Aleksi Hupli

Sociologist and Member of the Drugs Expert Group of the Civil Society Forum on Drugs, Tampere University, Finland

Vince Polito

Senior Researcher in Cognitive Sciences and Member of the Bimolecular Discovery Research Centre, Macquarie University, Australia

George Fejer

Team Coordinator of the ALIUS group, University of Konstanz, Germany

Dana Sawyer

Professor Emeritus of Philosophy and World Religions, Maine College of Art, United States

Rotem Petranker

Co-Founder and Director of the Psychedelic Science Research Program, University of Toronto, Canada

Samuli Kangaslampi

Clinical Psychologist and Founding Member of the Finnish Association for Psychedelic Research,Tampere University, Finland

Jan Thomann

Psychopharmacologist conducting Bioanalytical Analysis of Psychoactive Substances, University Hospital Basel, Switzerland

Jussi Jylkka

Philosopher, Psychologist, and Coordinator of the Finnish Network for Psychedelic Research , Åbo Akademi University, Finland

Lionel Thelen

Psycho-Anthropologist, Scientific Officer in the European Research Council, Belgium

Graham Campbell

Trial Psychiatrist, Hammersmith Medicines Research (seconded from Small Pharma Ltd & collaborating with Imperial College London), United Kingdom

Josjan Zijlmans

Post-doc at the Department of Child and Adolescent Psychiatry at the Amsterdam University Medical Center, The Netherlands

Michael Bogenschutz

Professor of Psychiatry & Director of the Langone Center for Psychedelic Medicine, NYU, United States

David Yaden

Assistant Professor in the Center for Psychedelic and Consciousness Research, Johns Hopkins University School of Medcine, United States

Metten Somers

Psychiatrist & Medical Director of the Affective and Psychotic Disorders Unit of the Department of Psychiatry, UMC Utrecht, The Netherlands

Michiel van Elk

Associate Professor & Supervisor of the Psychedelic, Religious, Spiritual, and Mystical Experiences Lab, Leiden University, The Netherlands

Jan Ramaekers

Professor and Head of the Psychopharmacology Department, Maastricht University, The Netherlands

Benjamin Kelmendi

Associate Research Scientist at the Department of Psychiatry, Yale University School of Medicine, United States

Ready To Attend ICPR 2024?

Join the leading conference in Europe dedicated to advancing psychedelic research and therapies.

Want The Latest Updates?

Subscribe below to ICPR Newsletter and get all the latest updates, including discount tickets!

By clicking subscribe, I confirm to receive emails from the OPEN Foundation and agree with its privacy & terms.